تسجيل الدخول
تسجيل جديد
الجمعة - رجب 27, 1447
مسجل لدى هيئة الحكومة الرقمية برقم:
20250728714
عن تيقظ
بحث عن منتج
تقديم بلاغ
أسئلة شائعة
تواصل معنا
EN
SA-13-01-26-1209
التفاصيل
الرقم المرجعي
الشركة الصانعة
اسم الجهاز الطبي
PRISMAFLEX SETS, OXIRIS SETS
الأجهزة المتأثرة
PRISMAFLEX M100 SET, PRISMAFLEX TPE 2000 SET, PRISMAFLEX ST100 SET, PRISMAFLEX ST150 SET, PRISMAFLEX M150 SET, OXIRIS SET ROW Please refer to the attachment for the affected Product Codes and Lot Numbers.
الممثل المعتمد
Baxter AG
سبب المشكلة
A potential dislodgement of the Prismaflex Set deaeration chamber from the Prismaflex Control Unit.
الإجراء التصحيحي
1. You may continue to perform therapy using the Prismaflex sets listed in the attachment. Please monitor the deaeration chamber during therapy to ensure it remains in an upright position within the holder. If attempting to secure the deaeration chamber in an upright position, please consider the following: - Ensure there are no kinks in the tubing and that the deaeration chamber remains visible. - If the Prismaflex Control Unit issues an “Air in Blood” alarm, check if air is present. If there is no air present, check if the deaeration chamber is dislodged from the holder and ensure there are no clots present. 1. If no dislodgement, please follow the operator’s manual instructions for “Air in Blood” alarm. 2. In case of dislodgement with clotting, follow the associated instructions within the Prismaflex Control Unit operator’s manual to stop the therapy and replace the set. 3. Only in case of dislodgement without clotting or any other alarms, if the chamber is secured in an upright position, follow the associated instructions within the Prismaflex Control Unit operator’s manual to proceed with treatment. Manufacturer's action: Instructions.
المرفقات
عودة للقائمة